Korean J Med.
2022 Dec;97(6):353-360. 10.3904/kjm.2022.97.6.353.
Updated Treatment Guidelines for Chronic Hepatitis B
- Affiliations
-
- 1Department of Gastroenterology and Hepatology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea
- KMID: 2536632
- DOI: http://doi.org/10.3904/kjm.2022.97.6.353
Abstract
- Chronic hepatitis B virus (HBV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma in Korea. While the prevalence of HBV infection is gradually declining in Korea, 3 of the population still suffers from HBV-related chronic liver diseases. In this review, we summarize the updated clinical guidelines for management of chronic HBV, as revised by the Korean Association for the Study of the Liver in 2022.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
- KASL clinical practice guidelines for management of chronic hepatitis B
- 2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different?
- 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis C: What's New?
- Updated Treatment of Chronic Hepatitis B
